An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3′-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients

Introduction: Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor prescribed as part of first-line highly active antiretroviral therapy (HAART) in South Africa. Despite administration of fixed doses of EFV, inter-individual variability in plasma concentrations has been reported. Poor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Genet
Hlavní autoři: Swart, Marelize, Evans, Jonathan, Skelton, Michelle, Castel, Sandra, Wiesner, Lubbe, Smith, Peter J., Dandara, Collet
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2016
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4703773/
https://ncbi.nlm.nih.gov/pubmed/26779253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2015.00356
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky